January 18-22, 2016 | Town and Country Resort Hotel | SAN DIEGO, CA 
January 18-22, 2016 | Town and Country Resort Hotel | SAN DIEGO, CA 

Poster Information

Present a Poster and Save $50!

Cambridge Healthtech Institute encourages attendees to gain further exposure by presenting their work in the poster sessions. To secure a poster board and inclusion in the conference materials, your abstract must be submitted, approved and your registration paid in full by November 20, 2015.

Register online, or by phone, fax or mail.  Please indicate that you would like to present a poster.  Once your registration has been fully processed, we will send an email with a unique link and instructions for submitting your abstract using our online abstract submission tool.  Please see below for more information.

Reasons you should present your research poster at this conference:

  • Your poster will be seen by our international delegation, representing leaders from top pharmaceutical, biotech, academic and government institutions
  • Receive $50 off your registration 
  • Your poster abstract will be published in our conference materials 
  • Automatically entered into poster competition


  • You must select ONE track for your poster.  (Your poster selection must be concurrent with your registration selection, but it does not have to be the same.)
  • Your poster will hang only for the duration of your selected track.
  • Late posters will only be accepted if space allows. Late posters will not be included in conference materials. 

Note: Posters should be portrait orientation, with maximum dimensions of
36 inches wide (3 feet) x 48 inches high (4 feet).

* CHI reserves the right to publish your poster title and abstract in various marketing materials and products.

Click here for poster instructions and guidelines.

Poster inquiries: jring@healthtech.com

Confirmed Research Posters Include:

Genetic Expression of New Insulin Analogue

Engineer Deimmunized Lysostaphin Variants to Combat Lethal MRSA Infections

Thermally Responsive TRAIL Receptor Agonist Fusions Are Potent Cancer Therapeutics

Developing Peptide Inhibitors for IDOL- Dependent LDLR Ubiquitination and Degradation

Engineered Albumins for Optimized Serum Half-Life Extension

Targeted Delivery of RNA Using Protein Conjugates for the Treatment of Atherosclerosis and Abdominal Aortic Aneurysms

Maximizing Cell Line Development Time: Minimizing FTE Time with Optimum Growth Flasks and Additions

Generating Focused Protein and Antibody Libraries for Protein Engineering

Engineering and Developability Assessment of Next Generation Antibodies

Notch Antibodies: Potential Cancer Immunotherapeutics

Crystalomics®: Order from Chaos

Crystalomics®: Injectable Crystal Suspensions

Crystalomics®: Scale Up and Characterization

Optimisation of Fermentation Conditions for the Production of Soluble and Active TNFa in E.coli

Definitive Screening Design-DoE Applied to Recombinant Protein Formulation

Novel Lipid Supplement Increases mAb Production in Single Use Bioreactors

Effect of Buffer Exchange on Protein Stability: A Comparison of Manual and Automated Techniques

Easy, Simple, and Fully Automated Formulation Development

Evaluating Manual and Automated Formulation Preparation Methods with Automated Analytics

Enzymatic Degradation of Polysorbate

Exploring Protein Stability by nanoDSF

Recombinant Human Albumin an Effective Approach to Formulate Hard-to-Stabilize Biopharmaceuticals

Mass Spec for Early Stage Developability Decisions Using Rituximab as a Model

RNArt® - Effective Delivery of Therapeutic Proteins by mRNA

Novel Transposase Tools for Cell-Line Engineering

Engineering Thermostable Enzymes Using Cell-Free Protein Synthesis at Elevated Temperatures

Engineering the CHO Cell

NHEJ-Mediated DNA Cloning and Manipulations in Yeast and Mammalian Cells

Studying the Model System ERK2-mAb: Determining Protein Stability Using nanoDSF and Characterizing the Molecular Interaction Using MicroScale Thermophoresis

Characterization of Proteins Using Coefficient of Determination Analysis for 2nd Derivative Spectroscopy

Chemical Modifications as Causes of Aggregation in Monoclonal Antibodies

Absolute Quantification of 5 Antibodies in Monkey Serum, CSF and Brain Lysate by MRM

Similar or Not? - An Innovative Method for Similarity Determination of Proteins and Biological Products with Surface Plasmon Resonance Sensors

Improved Performance Using Size Exclusion Chromatography in Product Lot Release

Mobile Phase Effects in Reversed-Phase Chromatography of Monoclonal Antibodies

Modulation of Pro-Apoptotic Signalling in Cancer Cells by Tricistronic Expression of RASSF1 and Its Associated Molecules

Intranasal Delivery of Leptin N-Terminal Conjugates with Pluronic P85 for Treatment of Obesity

Faster, Smaller, Deeper: Applications of UHPLC-SEC-MALS for Well-Characterized Biologics

Extractables Evaluation of a Single-Use Bioprocess Bag According to Published Recommendations

A Comparison of New EMD Millipore's Fully Enclosed TFF Capsule and a Pellicon® 3 Device in a mAb Bioprocess

Cell Debris Removal by Single-Use Diatomaceous Earth (DE) Filtration

The Use of Dynamic Control in Periodic Counter-Current Chromatography

The SB10-X, a New Orbital-Mixed 2L-12L Single Use Bioreactor for Cell Culture Scale-Up and Bulk Protein Production

Platform Purification of a Domain Antibody

Determining the 2.6 Å Structure of Human JAG1 Bound to the Fab Fragment of an Antagonistic Antibody

Rapid Fine Conformational Epitope Mapping Using Comprehensive Mutagenesis and Deep Sequencing

Assisted Design of Antibody and Protein Therapeutics (ADAPT) - Recent Advances in the Antibody Affinity Maturation Platform

Antibody Engineering of XMetD to Produce XOMA 129, a Rapidly Acting Insulin Receptor Modulator That Is a Potential Therapeutic Molecule for Treating Iatrogenic Hypoglycemia

Antibody Format and Drug Release Rate Determine the Therapeutic Activity of Noninternalizing Antibody-Drug Conjugates

New Workflow System for the Design and Evaluation of Antibody Drug Conjugates (ADCs)

A Novel Fully Human Anti-Mesothelin Antibody with an Efficient Internalization for the Development of Antibody-Drug Conjugate

Near Infrared Photoimmunotherapy for HER2 Positive Cancer

Direct IHC by Using PolyHRP Labeled Trastuzumab (Herceptin) - A Potential New Companion Diagnostic Test for Herceptin Treatment

Characterization of Human Liver Lysosomes

In Vivo Site-Specific Protein Tagging Using Engineered Sortase Variants

Cytotoxic Auristatin E-Affibody Conjugates That Target HER2-Positive Cancer Cells

Thermal Stable Anthrax Vaccine Formulation by Spray Drying

Impact of Lyophilization Processing and Formulation Composition on Pyroglutamate Formation in Lyophilized Protein Formulations

Spray Drying of a Domain Antibody (dAb)

Evaluating the Impact of Controlled Nucleation on Finished Product Attributes of Bulk Lyophilized Material

Continuous Intensified Lyophilisation

An Alternative Dehydration Process Enabling High Concentration Delivery of Biologics

Predicting Vial-to-Vial Variation in Maximum Temperature and Drying Time Within a Lyophilized Product Batch During Primary Drying

Production and Scale-Up of Amblyomin-X, an Antitumor Recombinant Protein

A Systematic Approach to Engineering Antibody Expression

A Panel of PIKK Enzymes Developed for Drug Discovery Applications

Performance and Application of PUREfrex 2.0 with Increased Productivity

Cell-Free Expression of High-Quality GPCRs in Eukaryotic and Prokaryotic Lysates

Dramatic Improvement in Recombinant Protein Yields Using a 96-Well High Throughput High-Speed Shaking Format and the Infors 3mm Orbit Multitron Pro

A Super Lipase: Engineering Lipase to Increase Substrate Accessibility by Fusion with Amphipathic and Coiled-Coil Peptide

Isolation of Novel Escherichia coli Mutant for the Enhanced Production of Therapeutic Proteins via the SRP-Dependent Secretion Pathway

Challenges Related to the Expression and Solubilization of Membrane-Associated Proteins

Improved Light-Inducible Mammalian Expression Using pJAZZ® Linear Vector

Improving Productivity in Transient Gene Expression Systems with FectoPROT, a Novel Powerful Transfection Solution

Fast and Convenient Method for Protein Production: Mammalian In Vitro Translation (Cell-Free) Systems for High-Yield Expression of Functional Proteins

Harnessing the Flexibility of the ExpiCHO Transient Expression System: New Protocols and Tips for Optimizing Protein Expression

Speed Improvement in Mid-Scale Biological Processes in: CHO, Hybridoma, HEK293 and Cell Lines: Single Use Optimum Growth Flasks 125mL-5L Flasks with Additional Features

Comparison of Imaging Flow Cytometry and Flow Microscopy for Analysis of Protein Particles

Identification and Quantification of Host Cell Proteins by Mass Spectrometry

Analyze Impurities and Confirm Identity with Sensitive Cy™5 Pre-Labeling for SDS-PAGE and Western Blot

Novel Technologies for the Characterization of Particles in Biotherapeutics

Impact of Pre-Filters on the Throughput of a Viral Filtration Step

Innovative Automated Small Scale Parallelized Biochromatography for High Throughput Method Development in Downstream Processing

Automating mAb Purification Workflows: Combining Tandem and Multi-D Purification Methodology with Sample Analysis

Novel Miniprep System for Rapid Purification of Recombinant Proteins and Antibodies on High Capacity Membranes

Advantages of KANEKA’s New Generation Protein A Resin

Novel Purification Method for Therapeutic Proteins Bearing Immunoglobin Fc Region

A Split Intein-Based Self-Cleaving Tag for Recombinant Protein Purification in a Mammalian Cell Expression System

Purification of Recombinant F(ab’)2 Antibody Fragments for PET Imaging

Development of a 20N Virus Filtration Process for Keyhole Limpet Hemocyanin (KLH) – A High Molecular Weight Protein

Standardizing Protein Quantification of Purified His-Tagged Proteins Using a Micro-Volume UV-Vis Reader with Spectral Content Profiling Software

Altered E.coli Membrane Protein Assembly Machinery Allows Proper Membrane Assembly of Eukaryotic Membrane Proteins

Molecular Cloning, Bacterial Expression and Functional Characterization of Membrane-Bound Cytochrome P450 Monooxygenase, CYP97C27, and NADPH-Cytochrome P450 Reductase, CPR I, Involved in the Biosynthesis of Anti-Peptic Plaunotol (18-OH Geranylgeraniol)

Expression and Purification of Mitochondrial Outer Membrane Proteins for Structural Study

Antibodies Against Difficult to Express Membrane Protein Targets

Engineering Antibodies for Improved Manufacturability

A Diverse Panel of Kv1.3 Antibodies Raised Through Chicken Immunization with Protozoan-Expressed Antigen

Direct Proteomic Sequencing of Monoclonal Antibodies

The NIH Protein Capture Reagent Initiative (PCRI): Generation and Validation of Monospecific Mouse Monoclonal Antibodies Against All Human Transcription Factors

Selection and Optimization of a scFv as a Targeting Ligand for a Cytotoxic Nanoparticle

Next-Generation DNA Sequencing Approaches for Discovery of Single-Domain Antibodies with Novel Phenotypes

Discovery and Characterization of Therapeutic Antibodies for an Engineered Cell-Free Expression System

Creation and Screening of a Lamprey Variable Lymphocyte Receptor Library Against Blood-Brain Barrier Endothelial Cell-Surface Antigens

Efficient Elimination of Carcinoma Cells Expressing the Tumor Exclusive Target CLDN6 with a Bispecific Antibody

An Investigation into the Mechanism of Faster Clearance of a mAb-dAb Bispecific Antibody

Engineered Bispecific Antibodies with Improved Developability

Structural Analysis of Proteins by Electron Microscopy

A Novel Bi-Specific FynomAb That Targets Both IL-6R and IL-17A

Characterization of the Multiheme C-Type Cytochrome from Geobacter sulfurreducens Designed for the Extrinsic Group Binding

New Approach for Detection and Visualization of Aggregation-Prone Regions

Studies on Development of Analytical Methods to Quantify Antibody Aggregates and Prediction of Soluble/Insoluble Aggregate-Formation

Evaluation of IgG4 Monoclonal Antibody Photostability to Support Process Characterization

Morphology of Alpha-1 Proteinase Inhibitor Aggregates Monitored Using Hydrogen Deuterium Exchange and Covalent Labeling Mass Spectrometry

Simultaneous Detection of Protein Aggregation and Affinity Measurements in a Single SPR Experiment

New Workflow Platform for High-Throughput Cell Line Development

Use of a Virus Barrier Filter to Protect Bioreactors from Virus Contamination

ActiPro™ Media System: Benchmarking, Scalability, and Protein Production in CHO Cell Culture

Solid-Phase Chromophore Maturation of GFP 1-10 for Improved Sensitivity and Rapidity of Split GFP Based CHO Cell Factory Screening

Employing Split-GFP and Droplet Microfluidics for the Selection of High-Producing CHO Cells

Quantitative Subcellular Fractionation of CHO Cells

Integrated System for Automated Cell Line Development, Including Use of Ambr Online Data

Optimization of Small Scale, High-Throughput Affinity Chromatography

A Platform for Antibody Expression Optimization: Miniaturized Transient Transfection of Expi293 and ExpiCHO Cells, and Antibody Purification

A Purification Platform for Hybridoma-Generated mAb's for Therapeutic Target Discovery R&D

A High-Throughput Purification Platform for Generation of a Comprehensive Human Protein Library

Big Difference in Protein Purification Process Economy